These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26994682)

  • 21. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of anticoagulants in patients with cancer.
    Lee AY
    Thromb Res; 2010 Apr; 125 Suppl 2():S8-11. PubMed ID: 20434012
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.
    Niers TM; Di Nisio M; Klerk CP; Baarslag HJ; Büller HR; Biemond BJ
    J Thromb Haemost; 2007 Sep; 5(9):1878-82. PubMed ID: 17723127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of venous thromboembolism: Time to measure our performance.
    Tan MWY; Chunilal S; Mansfield D
    Respirology; 2018 Mar; 23(3):246-247. PubMed ID: 29336519
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-related thrombosis in hematologic malignancies.
    Nadir Y; Hoffman R; Brenner B
    Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profound thrombocytopenia in previously treated patients with recurrent ovarian carcinoma receiving topotecan.
    Cass I; Kuo DY; Fields AL; Runowicz CD; Goldberg GL
    Gynecol Oncol; 1998 May; 69(2):175-8. PubMed ID: 9600828
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
    Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
    Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of venous thromboembolism in cancer patients.
    Lee AY
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):93-101. PubMed ID: 19285276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia.
    Unkle DW
    Orthop Nurs; 2007; 26(6):383-5; quiz 386-7. PubMed ID: 18046215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Ferrante N; De Tursi M; Iacobelli S; Cuccurullo F; Büller HR; Feragalli B; Porreca E
    Thromb Haemost; 2010 Nov; 104(5):1049-54. PubMed ID: 20806119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism prophylaxis and treatment in patients with cancer.
    Kakkar AK
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):416-7. PubMed ID: 18567985
    [No Abstract]   [Full Text] [Related]  

  • 33. Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia.
    Ploppa A; Haeberle L; Schmid E; Nohe B
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4):744-8. PubMed ID: 22236793
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer, thrombosis and heparin-induced thrombocytopenia.
    Prandoni P; Falanga A; Piccioli A
    Thromb Res; 2007; 120 Suppl 2():S137-40. PubMed ID: 18023709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative value of platelet size indices for the identification of the mechanism of chemotherapy-induced thrombocytopenia.
    ten Berg MJ; Huisman A; van den Bemt PM; den Breeijen H; Egberts TC; van Solinge WW
    Biomarkers; 2011 Feb; 16(1):51-7. PubMed ID: 20977409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
    Kami M; Hori A; Takaue Y; Mutou Y
    Clin Infect Dis; 2002 Jul; 35(1):105-6; author reply 106-7. PubMed ID: 12060886
    [No Abstract]   [Full Text] [Related]  

  • 37. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caelyx-induced unilateral erythrodysesthaesia secondary to venous thromboembolism.
    Merika EE; Gore M; Fearfield LA
    Eur J Dermatol; 2017 Jun; 27(3):321-322. PubMed ID: 28468742
    [No Abstract]   [Full Text] [Related]  

  • 39. Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome.
    Baelum JK; Moe EE; Nybo M; Vinholt PJ
    Clin Appl Thromb Hemost; 2017 May; 23(4):345-350. PubMed ID: 26512063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
    Wharin C; Tagalakis V
    Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.